MDI Biological Laboratory launches new program

BAR HARBOR — The MDI Biological Laboratory (MDIBL) has named James S. Strickland as director of MDI Bioscience, a new initiative focused on using non-mammalian models in early drug discovery and development.  

Strickland brings a wealth of pharmaceutical development experience to his new position, in which he will leverage the MDI Biological Laboratory’s 124-year history of using non-mammalian animal models such as zebrafish and C. elegans for scientific research to fill a need in pharmaceutical discovery and development for pre-clinical models that bridge the gap between isolated systems such as cell cultures and mammals such as the mouse or rat.  Read more

Related Posts

Maine’s startup ‘mojo’ highlighted in national ranking

As a place to start a business, Maine’s “mojo” is going strong, as shown in a new national ranking released Tuesday by WalletHub,...

19 January 2023

Maine CDC Director Nirav Shah to join U.S. CDC leadership

Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention, has been appointed principal deputy director at the...

13 January 2023

$5.6M in state funding to support Maine startups, entrepreneurs

Sixteen Maine organizations helping startups and entrepreneurs will share $5.6 million in state funding from the Pandemic Recovery for an Innovative Maine...

11 January 2023